The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 19, 2024

Filed:

Mar. 27, 2019
Applicant:

Xyphos Biosciences Inc., South San Francisco, CA (US);

Inventors:

Kaman C. Kim, San Bruno, CA (US);

Kyle E. Landgraf, Alameda, CA (US);

Assignee:

XYPHOS BIOSCIENCES INC., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/74 (2006.01); A61K 35/17 (2015.01); A61P 35/00 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); C07K 16/46 (2006.01); C07K 19/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/7056 (2013.01); A61K 35/17 (2013.01); A61P 35/00 (2018.01); C07K 14/70539 (2013.01); C07K 16/2833 (2013.01); C07K 16/2851 (2013.01);
Abstract

This present disclosure relates generally to the production of polypeptides comprised of modified α1-α2 domains of NKG2D ligands which bind specifically to a non-natural ectodomain of a non-natural NKG2D receptor and wherein heterologous molecules are attached to the modified α1-α2 domains of NKG2D ligands. The present disclosure further relates to modified α1-α2 domains of NKG2D ligands attached to heterologous molecules including polypeptides, and in some embodiments, antibodies or fragments of antibodies. The present disclosure also relates to modified forms of the NKG2D receptor engineered to provide a combination of enhanced and diminished binding to non-natural and natural versions of NKG2D ligands, respectively.


Find Patent Forward Citations

Loading…